Large-scale testing (Phase 3)Ended earlyNCT01202773What this trial is testingA Study in Participants With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Eli Lilly and Company 456
Large-scale testing (Phase 3)WithdrawnNCT02242656What this trial is testingA Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-DiarrhealsWho this might be right forShort Bowel SyndromeShort Gut SyndromeSBS+2 more Marathon Pharmaceuticals, LLC
Post-approval studies (Phase 4)Study completedNCT00539071What this trial is testingHigh Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to RisperidoneWho this might be right forSchizophreniaSchizoaffective Disorder Northwestern University 160
Testing effectiveness (Phase 2)UnknownNCT06490484What this trial is testingEfficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to PregabalinWho this might be right forDiabetic Peripheral Neuropathic Pain Haisco Pharmaceutical Group Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT02141997What this trial is testingInvestigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis AbbVie 222
Large-scale testing (Phase 3)Study completedNCT02889796What this trial is testingFilgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Gilead Sciences 1,759
Large-scale testing (Phase 3)Study completedNCT02007629What this trial is testingRiociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 InhibitorWho this might be right forHypertension, Pulmonary Bayer 61
Not applicableStudy completedNCT01388309What this trial is testingAn Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDsWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 64
Testing effectiveness (Phase 2)Looking for participantsNCT07137598What this trial is testingAssess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 160
Large-scale testing (Phase 3)Not Yet RecruitingNCT07781293What this trial is testingStudy of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant MonotherapyWho this might be right forMajor Depressive Disorder (MDD)Major Depressive Disorder With Psychotic Features Bukwang Pharmaceutical 364
Early research (Phase 1)Looking for participantsNCT04811703What this trial is testingPressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian CancerWho this might be right forMetastatic Ovarian CarcinomaPeritoneal CarcinomatosisStage III Ovarian Cancer+4 more Hospices Civils de Lyon 15
Post-approval studies (Phase 4)Study completedNCT01059773What this trial is testingA Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to MethotrexateWho this might be right forPsoriasis Janssen-Cilag International NV 490
Large-scale testing (Phase 3)Study completedNCT00965757What this trial is testingA Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Eisai Co., Ltd. 253
Post-approval studies (Phase 4)Study completedNCT01195272What this trial is testingThe Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs.Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 21
Large-scale testing (Phase 3)Active Not RecruitingNCT06945107What this trial is testingSwitching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody TherapyWho this might be right forPlaque Psoriasis Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 308
Large-scale testing (Phase 3)Study completedNCT05550532What this trial is testingAticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant TherapyWho this might be right forDepressive Disorder, MajorAnhedonia Janssen Research & Development, LLC 444
Large-scale testing (Phase 3)Study completedNCT02203032What this trial is testingGuselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to UstekinumabWho this might be right forPsoriasis Janssen Research & Development, LLC 872